Top-News
Gesundheitswesen USA

Durect News

Aktie
WKN:  A3DZZ2 ISIN:  US2666055007 US-Symbol:  DRRX
0,87 €
-0,025 €
-2,79%
17.04.24 21:20:03
Handeln Depot/Watchlist
Aktienanzahl *
29,83 Mio.
Marktkapitalisierung *
26,93 Mio. €
Streubesitz
-
Index-Zugehörigkeit
Nasdaq Composite Index
IR-Website
zur Website
*Stand: 31.03.2024

Durect News

30.04.24 - PR Newswire
DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis
DURECT Corporation Announces Late-​Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-​Associated Hepatitis PR Newswire
27.03.24 - PR Newswire
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update PR Newswire
20.03.24 - PR Newswire
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update PR Newswire
04.03.24 - PR Newswire
DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada
DURECT and Charles River Laboratories Enter into Co-​Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada PR Newswire
22.02.24 - PR Newswire
Thinking about buying stock in Vermilion Energy, Staffing 360 Solutions, DURECT, Root Inc, or Ventyx Biosciences?
Thinking about buying stock in Vermilion Energy, Staffing 360 Solutions, DURECT, Root Inc, or Ventyx Biosciences? PR Newswire
07.02.24 - PR Newswire
DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference PR Newswire
13.11.23 - PR Newswire
DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update
DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update PR Newswire
09.11.23 - PR Newswire
DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update
DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update PR Newswire
07.11.23 - PR Newswire
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on Mortality
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-​Associated Hepatitis with Promising Effect on Mortality PR Newswire
31.08.23 - PR Newswire
DURECT Corporation Announces Presentations in Upcoming Investor Conferences
DURECT Corporation Announces Presentations in Upcoming Investor Conferences PR Newswire
09.08.23 - PR Newswire
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update PR Newswire
03.08.23 - PR Newswire
DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business Update
DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business Update PR Newswire
20.07.23 - PR Newswire
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-​The-Market Under Nasdaq Rules PR Newswire
07.06.23 - PR Newswire
DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis
DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-​Associated Hepatitis PR Newswire
08.05.23 - PR Newswire
DURECT Corporation Reports First Quarter 2023 Financial Results and Business Update
DURECT Corporation Reports First Quarter 2023 Financial Results and Business Update PR Newswire
01.05.23 - PR Newswire
DURECT Corporation to Announce First Quarter 2023 Financial Results and Provide Business Update on May 8
DURECT Corporation to Announce First Quarter 2023 Financial Results and Provide Business Update on May 8 PR Newswire
27.04.23 - PR Newswire
DURECT Corporation to Host KOL Event on Alcohol-Associated Hepatitis
DURECT Corporation to Host KOL Event on Alcohol-​Associated Hepatitis PR Newswire
25.04.23 - PR Newswire
DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference
DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference PR Newswire
10.04.23 - PR Newswire
DURECT Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2a Study of Larsucosterol in Alcohol-Associated Hepatitis
DURECT Announces Peer-​Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2a Study of Larsucosterol in Alcohol-​Associated ...
21.03.23 - PR Newswire
DURECT Corporation Announces Appointment of Gail Maderis as Chair of the Board
DURECT Corporation Announces Appointment of Gail Maderis as Chair of the Board PR Newswire

Newssuche

Videos

newspaper
30.04.24 +8,65%
Technical Trading: Sojabohnen Long bis Juli
Sojabohnen Long Typ: Turbo Open End WKN: VX41AH Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »